Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of cathepsin K inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure

Use of cathepsin K inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure

US Patent 9943522 · Granted Apr 17, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Atrial natriuretic peptide engrafted antibodies2025
Substituted pyrazolo piperidine carboxylic acids2025
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of 2024
Supporting patients in the repeated taking of drugs2023
7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof2022
Prodrugs of substituted triazole derivatives and uses thereof2022
Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 i2021
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of 2021
Amide-substituted pyridinyltriazole derivatives and uses thereof2021
7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof2021
Amide-substituted phenyltriazole derivatives and uses thereof2020
2-phenyl-3-(piperazinomethyl)imidazo[1,2-A]pyridine derivatives as blockers of t2020